It has been five years since the World Health Organisation (WHO) declared COVID-19 a pandemic in March 2020 a decision that ...

Moderna, Inc. ( NASDAQ: MRNA) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ET All right, well, good morning, everyone. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen.

A team of Yale researchers recently published promising results from a clinical trial testing the effectiveness of a new ...

Moderna stock skidded on reports Robert F. Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock ...

A personalized vaccine demonstrated the potential to induce long-lasting immune response among people with advanced kidney ...

Uganda's Ebola virus caseload has risen to 12, up from 10, with two people who died early last month being considered ...

Dolly Parton has an estimated net worth of $450 million, according to Forbes. Her Dollywood theme parks and music catalog are ...

Today's actions expand on Arbutus and Genevant's ongoing enforcement proceeding in the U.S. District Court for the District ...

Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...

Moderna’s arch-rival in the mRNA vaccine category ... FDA review as a lung cancer treatment with a decision due in the third quarter.

BASEL, Switzerland and VANCOUVER, British Columbia and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a ...